← SG Capital PCL overview

SG Capital PCL vs Synchrony Financial: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

SG Capital PCL (SGC.BK)

Q3 2026
▲3

Record Profit, C4C Sale, Loss Clearance Boost SGC

  • Record Q2 profit SGC posted record Q2 net profit of 203.5 million baht, up 186% from a year earlier, with first-half profit up 229% to 379.7 million baht, driven by Lock Phone loans that made up 97% of new lending and beat the 14-billion-baht target.

    This is the main positive earnings news that drove the stock.

  • C4C portfolio sale The board approved selling its C4C loan portfolio for up to 1.3 billion baht, which will boost liquidity in the fourth quarter and delay the need for new bond issuance.

    This is a new strategic move that improves cash flow and reduces funding needs.

  • Loss clearance approved Shareholders approved clearing 856 million baht in accumulated losses, removing a barrier to dividends after eight profitable quarters.

    This is a new shareholder decision that opens the door to future dividends.

  • Risks and regulation Management welcomed stricter Bank of Thailand non-bank lending rules, but growth is heavily concentrated in the high-yield Lock Phone product, the C4C sale shifts focus away from that portfolio, and dividend payments remain only a possibility, not yet confirmed.

    This provides a fair counterweight by highlighting risks despite the positive news.

September 2026
▲3

Record Profit, C4C Sale, Loss Clearance Boost SGC

  • Record Q2 profit SGC posted record Q2 net profit of 203.5 million baht, up 186% from a year earlier, with first-half profit up 229% to 379.7 million baht, driven by Lock Phone loans that made up 97% of new lending and beat the 14-billion-baht target.

    This is the main positive earnings news that drove the stock.

  • C4C portfolio sale The board approved selling its C4C loan portfolio for up to 1.3 billion baht, which will boost liquidity in the fourth quarter and delay the need for new bond issuance.

    This is a new strategic move that improves cash flow and reduces funding needs.

  • Loss clearance approved Shareholders approved clearing 856 million baht in accumulated losses, removing a barrier to dividends after eight profitable quarters.

    This is a new shareholder decision that opens the door to future dividends.

  • Risks and regulation Management welcomed stricter Bank of Thailand non-bank lending rules, but growth is heavily concentrated in the high-yield Lock Phone product, the C4C sale shifts focus away from that portfolio, and dividend payments remain only a possibility, not yet confirmed.

    This provides a fair counterweight by highlighting risks despite the positive news.

Latest
▲4

SGC's profit surge, loss clearance and loan growth drive gains

  • First-half profit jumps 229% on Lock Phone loans SGC's first-half net profit surged 229% to 379.7 million baht, powered by Lock Phone loans that made up 97% of new lending. This shows the core business is booming and supports a higher stock price.

    It gives the latest profit numbers and confirms the main growth engine, which is central to why the stock is moving.

  • SGC clears 856 million baht in accumulated losses SGC will wipe out 856 million baht of accumulated losses by transferring reserves and share premium. This removes a barrier to paying dividends, making the stock more attractive to income-focused investors.

    It is a concrete step that unlocks future dividends, a key reason investors are buying.

  • Shareholders approve loss clearance, paving way for dividends At the September 29 meeting, shareholders unanimously approved clearing accumulated losses. This final approval means SGC can now consider paying dividends, a positive catalyst for the stock.

    It is the final regulatory step that makes future dividends possible, directly affecting investor expectations.

  • New BOT rules seen as positive for SGC SGC welcomed the Bank of Thailand's stricter rules for non-bank lenders, saying its systems are ready. Clearer regulation can boost confidence and support the stock price.

    It shows SGC is well-prepared for regulatory changes, reducing uncertainty and supporting the stock.

▲4

SGC's record profit, C4C sale and Lock Phone boom drive gains

  • Record Q2 profit and strong group momentum SGC posted a record quarterly net profit of 203.5 million baht, up 186% from a year earlier, as part of the JMART group's broad recovery. This profit surge, plus the group's growth plans, supports the stock price by showing the business is performing well.

    It is the core earnings event that explains why SGC is moving and is new this period.

  • C4C portfolio sale to boost Q4 cash and results SGC's board approved selling its C4C car-for-cash loan portfolio for up to 1.3 billion baht, with about 1 billion baht expected in Q4 2026. This improves liquidity, lets it delay new bond issuance, and sets up a record fourth quarter, pushing the stock up.

    It is a concrete new transaction that directly affects SGC's cash flow and future earnings.

  • Lock Phone lending beats expectations SGC's Lock Phone loan disbursements rose about 20% in July-August and demand kept rising in September, putting it on track to exceed its 14 billion baht full-year target. Nearly 90% of new loans are Lock Phone, a high-yield product, which supports revenue growth.

    It shows the main growth engine is stronger than planned, a key reason the stock is moving.

  • Capital restructuring and possible dividends ahead SGC and SINGER will hold an extraordinary shareholder meeting on September 29 to consider capital restructuring and future dividend plans. After eight straight profitable quarters, clearing accumulated losses could unlock dividends, a positive for the stock price.

    It is a new corporate action that could change the stock's appeal to income-focused investors.

Synchrony Financial (SYF)

Q3 2026
▲2▼2

Synchrony's record growth offset by credit strain and regulatory risk

  • Record purchase volume and broad growth Synchrony posted record Q2 purchase volume of $49.8 billion, with growth in all five business lines, a 24.5% earnings beat, and raised 2026 guidance. The company also returned $950 million to shareholders.

    This highlights the core positive operational and financial results that drove the quarter.

  • AI partnerships and CareCredit expansion Synchrony announced AI partnerships with OpenAI and expanded CareCredit into Stripe and Vetspire, signaling innovation and new distribution channels that could support future growth.

    This points to strategic initiatives that may drive future performance and investor optimism.

  • Credit strain amid high inflation Inflation at 4.2% and over a quarter of customers with credit scores below 660 pushed delinquencies to an 18-year high, raising concerns about credit quality and potential loan losses.

    This is a key risk factor that weighed on the stock and could pressure future earnings.

  • Slow revenue growth and regulatory threat Q2 revenue missed estimates, growing just 1.9%—the slowest among card peers—and shares fell. The Credit Card Competition Act, backed by Trump and Vance, threatens swipe fees, though passage remains unlikely.

    This captures the revenue weakness and regulatory overhang that offset positive developments.

August 2026
▲2▼2

Synchrony's record card spending and CareCredit deals offset a revenue miss and looming swipe-fee threat

  • Record purchase volume points to stronger second-half earnings Synchrony's Q2 purchase volume hit a record $49.8 billion, up 8% from a year ago, with growth in all five business lines and co-branded cards up 23%. Management expects this spending to lift loan balances and earnings in the second half, a positive for the stock.

    This is the core positive force behind SYF: more card spending should drive future revenue and profit.

  • CareCredit expands into Stripe and Vetspire payment platforms Synchrony plugged its CareCredit health-care card into Stripe's payment system and Vetspire's veterinary software, giving millions of cardholders and thousands of clinics easier ways to offer financing. More places to use the card means more transaction volume over time.

    These partnerships are new distribution channels that can grow SYF's health-care lending and fee income.

  • Q2 revenue growth was the slowest among card peers Synchrony's Q2 revenue rose just 1.9% to $3.72 billion and missed analyst estimates by 0.7%, the weakest growth among six tracked card stocks. Even though profit beat expectations, the soft top line and a 2% share drop since reporting weigh on sentiment.

    It is the main negative fundamental datapoint this period and explains recent share-price weakness.

  • Credit Card Competition Act gains political momentum Trump and Vance backed the Credit Card Competition Act, which would force big banks to offer at least two payment networks per card and could lower swipe fees. Synchrony, as a card issuer, would earn less on each transaction if it passes, though the industry still sees it as unlikely to become law.

    This is a real regulatory risk that could pressure SYF's fee revenue if it advances.

Latest
▲2▼2

Synchrony's record card spending and CareCredit deals offset a revenue miss and looming swipe-fee threat

  • Record purchase volume points to stronger second-half earnings Synchrony's Q2 purchase volume hit a record $49.8 billion, up 8% from a year ago, with growth in all five business lines and co-branded cards up 23%. Management expects this spending to lift loan balances and earnings in the second half, a positive for the stock.

    This is the core positive force behind SYF: more card spending should drive future revenue and profit.

  • CareCredit expands into Stripe and Vetspire payment platforms Synchrony plugged its CareCredit health-care card into Stripe's payment system and Vetspire's veterinary software, giving millions of cardholders and thousands of clinics easier ways to offer financing. More places to use the card means more transaction volume over time.

    These partnerships are new distribution channels that can grow SYF's health-care lending and fee income.

  • Q2 revenue growth was the slowest among card peers Synchrony's Q2 revenue rose just 1.9% to $3.72 billion and missed analyst estimates by 0.7%, the weakest growth among six tracked card stocks. Even though profit beat expectations, the soft top line and a 2% share drop since reporting weigh on sentiment.

    It is the main negative fundamental datapoint this period and explains recent share-price weakness.

  • Credit Card Competition Act gains political momentum Trump and Vance backed the Credit Card Competition Act, which would force big banks to offer at least two payment networks per card and could lower swipe fees. Synchrony, as a card issuer, would earn less on each transaction if it passes, though the industry still sees it as unlikely to become law.

    This is a real regulatory risk that could pressure SYF's fee revenue if it advances.

July 2026
▲2▼2

Synchrony's AI push and raised outlook offset credit and inflation worries

  • Inflation and subprime strain Inflation hit a 3-year high of 4.2%, squeezing lower-income households. With over a quarter of Synchrony's customers below 660 credit scores and delinquencies at an 18-year high, defaults could rise and spending could slow, pressuring the stock.

    This is the core fundamental risk weighing on Synchrony's business and stock.

  • Q2 revenue miss Synchrony's Q2 revenue of $4.61 billion fell short of the $4.66 billion estimate, sending shares down 1.6%. The miss shows the company isn't growing as fast as expected, which can hold the stock back.

    A concrete earnings miss that directly affects investor confidence and valuation.

  • OpenAI partnership for in-chat shopping Synchrony is working with OpenAI to let shoppers buy directly inside ChatGPT using store cards, and is talking to Anthropic and Google about similar deals. This could expand card usage and reach new customers, a long-term positive.

    A new growth avenue that could boost demand for Synchrony's cards and services.

  • Q2 EPS beat and raised 2026 outlook Synchrony beat Q2 EPS estimates by 24.5% and raised the low end of its 2026 EPS guidance to $9.25–$9.50. Loan receivables and purchase volume grew, and the company returned $950 million to shareholders, signaling financial strength.

    Strong earnings and improved guidance directly support the stock price.

▲2▼2

Synchrony's AI push and raised outlook offset credit and inflation worries

  • Inflation and subprime strain Inflation hit a 3-year high of 4.2%, squeezing lower-income households. With over a quarter of Synchrony's customers below 660 credit scores and delinquencies at an 18-year high, defaults could rise and spending could slow, pressuring the stock.

    This is the core fundamental risk weighing on Synchrony's business and stock.

  • Q2 revenue miss Synchrony's Q2 revenue of $4.61 billion fell short of the $4.66 billion estimate, sending shares down 1.6%. The miss shows the company isn't growing as fast as expected, which can hold the stock back.

    A concrete earnings miss that directly affects investor confidence and valuation.

  • OpenAI partnership for in-chat shopping Synchrony is working with OpenAI to let shoppers buy directly inside ChatGPT using store cards, and is talking to Anthropic and Google about similar deals. This could expand card usage and reach new customers, a long-term positive.

    A new growth avenue that could boost demand for Synchrony's cards and services.

  • Q2 EPS beat and raised 2026 outlook Synchrony beat Q2 EPS estimates by 24.5% and raised the low end of its 2026 EPS guidance to $9.25–$9.50. Loan receivables and purchase volume grew, and the company returned $950 million to shareholders, signaling financial strength.

    Strong earnings and improved guidance directly support the stock price.